Key result
MoGAT-2 inhibitors emerge as a potential therapeutic approach for treating hypertriglyceridemia.
Answers are grounded in this paper and cite their sources.
MoGAT-2 inhibitors remain hypothesis-generating for hypertriglyceridemia; leaves open the need for clinical validation of patented scaffolds.
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTMoGAT-2 Inhibitors May Provide Effective Treatment for HypertriglyceridemiaAhmed F. Abdel-Magid*View Author Information Therachem Research Medilab (India) Pvt. Ltd., Jaipur, India*Address: 1383 Jasper Drive, Ambler, Pennsylvania 19002, United States. Tel: 215-913-7202. E-mail: [email protected]Cite this: ACS Med. Chem. Lett. 2014, 5, 8, 840–841Publication Date (Web):June 6, 2014Publication History Received26 May 2014Published online6 June 2014Published inissue 14 August 2014https://pubs.acs.org/doi/10.1021/ml500217ghttps://doi.org/10.1021/ml500217geditorialACS PublicationsCopyright © 2014 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views915Altmetric-Citations1LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstract
No takes yet. Share an insight, caveat, or question.
Ahmed F. Abdel‐Magid (2014) conducted an editorial in Hypertriglyceridemia. MoGAT-2 Inhibitors was evaluated. This patent highlight discusses MoGAT-2 inhibitors as a potential treatment for hypertriglyceridemia.
Synapse has enriched 10 related papers. Consider them for comparative context: